10 Recruiting Studies Using Cediranib Maleate
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Cediranib Maleate
Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
📍 UC San Diego Moores Cancer Center — La Jolla, California
Recurrent Glioblastoma
View Study & Checklist ➔Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Fallopian Tube Clear Cell Adenocarcinoma
View Study & Checklist ➔Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
📍 Cedars-Sinai Medical Center — Los Angeles, California
Fallopian Tube Carcinoma
View Study & Checklist ➔Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Fallopian Tube Clear Cell Adenocarcinoma
View Study & Checklist ➔Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies
📍 Mayo Clinic in Florida — Jacksonville, Florida
Metastatic Melanoma
View Study & Checklist ➔Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
📍 Highlands Oncology Group - Rogers — Rogers, Arkansas
Epithelioid Mesothelioma
View Study & Checklist ➔Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Endometrial Adenocarcinoma
View Study & Checklist ➔Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Fallopian Tube Mucinous Adenocarcinoma
View Study & Checklist ➔A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
📍 UC San Diego Moores Cancer Center — La Jolla, California
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Fallopian Tube Carcinoma
View Study & Checklist ➔